<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>110th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 2221</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20071023">October 23, 2007</action-date>
			<action-desc><sponsor name-id="S153">Mr. Grassley</sponsor> (for
			 himself and <cosponsor name-id="S161">Mr. Specter</cosponsor>) introduced the
			 following bill; which was read twice and referred to the
			 <committee-name committee-id="SSFI00">Committee on
			 Finance</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend title XVIII of the Social Security Act to
		  provide for the reporting of sales price data for implantable medical
		  devices.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short
			 title</header><text display-inline="no-display-inline">This Act may be cited as
			 the <quote><short-title>Transparency in Medical Device
			 Pricing Act of 2007</short-title></quote>.</text>
		</section><section id="id56AFB3D809F14ABB8C8619B3A11DC795"><enum>2.</enum><header>Reporting of
			 sales price data for implantable medical devices</header><text display-inline="no-display-inline">Title XVIII of the Social Security Act (42
			 U.S.C. 1395 et seq.) is amended by adding at the end the following new
			 section:</text>
			<quoted-block display-inline="no-display-inline" id="id1249F21C2C114E72A4FF93EF9CED51EB" style="OLC">
				<section id="id3269A67CFBEA482796D0FE5E3F2E4583"><enum>1898.</enum><header>Reporting of
				sales price data for implantable medical devices</header>
					<subsection id="idE757B5368C30409F9CF6A8CC6D5A053A"><enum>(a)</enum><header>Collection of
				sales price data</header>
						<paragraph id="id0B83DC3FE578423FA720B9AD9A263638"><enum>(1)</enum><header>Quarterly
				reports from manufacturers of covered medical devices</header><text>Not later
				than the date that is 30 days after the last day of each fiscal year quarter
				beginning on or after January 1, 2009, in the case of a covered medical device
				that is used in a procedure identified under subsection (b), each manufacturer
				of such device shall submit to the Secretary, in such form as the Secretary
				shall require, the following:</text>
							<subparagraph id="id2720B0BEB65B4938925E0501238A2823"><enum>(A)</enum><text>The name of the
				manufacturer of the covered medical device.</text>
							</subparagraph><subparagraph id="idC4AEAB52E0D94DC8A4039414FD6DBEBC"><enum>(B)</enum><text>The name of the
				covered medical device.</text>
							</subparagraph><subparagraph id="idE97871F599CA492B9A817F2B065DC7DB"><enum>(C)</enum><text>The category type
				of the covered medical device (using a nomenclature specified by the Secretary
				for categorizing medical devices in order to ensure consistent
				reporting).</text>
							</subparagraph><subparagraph id="id4D2564ADCCC742A489F4E1E8E6DA41BE"><enum>(D)</enum><text>The hospital
				inpatient procedure or hospital outpatient procedure identified under
				subsection (b) with respect to which the medical device was used during the
				quarter.</text>
							</subparagraph><subparagraph id="id826655F8580F4283B14D27D1DF16DF3F"><enum>(E)</enum><text>The average and
				median sales price of the covered medical device.</text>
							</subparagraph><subparagraph id="id855C98C364FC44A9A22E6B0D3231C906"><enum>(F)</enum><text>Such other
				information as the Secretary requires, including the unit of measure used to
				determine the number of medical devices sold by the manufacturer.</text>
							</subparagraph></paragraph><paragraph id="id9D05FFD66916490BA37C3DF99D9A407D"><enum>(2)</enum><header>Penalties for
				noncompliance</header>
							<subparagraph id="id21809C86852B49D9A4E70A0F5E2F957E"><enum>(A)</enum><header>Failure to
				submit information</header><text>Any manufacturer of a covered medical device
				that fails to submit information required under paragraph (1) in accordance
				with regulations promulgated to carry out such paragraph, shall be subject to a
				civil money penalty of not less than $10,000, but not more than $100,000, for
				each such failure.</text>
							</subparagraph><subparagraph id="idF5E42DE2A2A1420888831948AF0A8D3B"><enum>(B)</enum><header>Misrepresentation</header><text>Any
				manufacturer of a covered medical device that misrepresents the average or
				median sales price of such device in information submitted under paragraph (1)
				shall be subject to a civil money penalty of not less than $10,000, but not
				more than $100,000, for each such misrepresentation and for each day in which
				such misrepresented average or median sales price is made publicly available
				under subsection (c).</text>
							</subparagraph><subparagraph id="id894260A3E5FE4D5198A89B3E186090A0"><enum>(C)</enum><header>Imposition and
				collection</header><text>A penalty under subparagraph (A) or (B) shall be
				imposed and collected in the same manner as civil money penalties under
				subsection (a) of section 1128A are imposed and collected under that
				section.</text>
							</subparagraph></paragraph><paragraph id="ID16d151b93de64e80b19e005cee053a60"><enum>(3)</enum><header>Definitions</header><text>In
				this section:</text>
							<subparagraph id="idD5C3832216FE481291014F3424930C1F"><enum>(A)</enum><header>Average sales
				price</header>
								<clause id="idEAFF802DF60342FFBF2C8739CCE512E2"><enum>(i)</enum><header>In
				general</header><text>Subject to clauses (ii) and (iii), the term <term>average
				sales price</term> means, of a covered medical device for a fiscal year quarter
				for a manufacturer for a unit—</text>
									<subclause id="id92B1E83983D4432984A3B5F8B74F147A"><enum>(I)</enum><text>the
				manufacturer’s sales to all purchasers (excluding sales exempted in clause
				(ii)) in the United States for such covered medical device in the quarter;
				divided by</text>
									</subclause><subclause id="id0069F8A2FA3E4560B7A65AE02AFB4BFD"><enum>(II)</enum><text>the total number
				of such units of such covered medical device sold by the manufacturer in such
				quarter.</text>
									</subclause></clause><clause id="idF9D77E59487B400691FA83B1177F5073"><enum>(ii)</enum><header>Certain sales
				exempted from computation</header><text>In calculating the manufacturer’s
				average sales price under this subparagraph, certain sales may be excluded in
				the case where the Secretary determines such exclusion is appropriate.</text>
								</clause><clause id="id279C1CDAE20E480AB9A5940C6CCDC345"><enum>(iii)</enum><header>Sale price
				net of discounts</header><text>In calculating the manufacturer’s average sales
				price under this subparagraph, such price shall include volume discounts, cash
				discounts, free goods and services that are contingent on any purchase
				requirement, chargebacks, and rebates, and any other discounts or price
				concessions the Secretary determines to be appropriate (using a methodology
				developed by the Secretary to estimate costs during the quarter that are
				attributable to discounts and price concessions).</text>
								</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id4B041E7BFEDA463097B9E6116E5F2942"><enum>(B)</enum><header>Covered medical
				device</header><text>The term <term>covered medical device</term> means any
				device for which payment is available under title XVIII or a State plan under
				title XIX or XXI (or a waiver of such a plan).</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="idA804375F9FB74CDC89012A285C68E36D"><enum>(C)</enum><header>Median sales
				price</header>
								<clause commented="no" id="idE532168463ED43E6BB33EC84CECC442D"><enum>(i)</enum><header>In
				general</header><text>Subject to clauses (ii) and (iii), the term <term>median
				sales price</term> means, of a covered medical device for a fiscal year quarter
				for a manufacturer for a unit, the median of all sales by the manufacturer to
				purchasers (excluding sales exempted in clause (ii)) in the United States for
				such covered medical device in the quarter.</text>
								</clause><clause id="id722C2602A6CF474298A963909A91A5E7"><enum>(ii)</enum><header>Certain sales
				exempted from computation</header><text>In calculating the manufacturer’s
				median sales price under this subparagraph, certain sales may be excluded in
				the case where the Secretary determines such exclusion is appropriate.</text>
								</clause><clause id="id6B1D9C69492942178D2F1081E3FCDEAF"><enum>(iii)</enum><header>Sale price
				net of discounts</header><text>In calculating the manufacturer’s median sales
				price under this subparagraph, such price shall include volume discounts, cash
				discounts, free goods and services that are contingent on any purchase
				requirement, chargebacks, and rebates, and any other discounts or price
				concessions the Secretary determines to be appropriate (using a methodology
				developed by the Secretary to estimate costs during the quarter that are
				attributable to discounts and price concessions).</text>
								</clause></subparagraph></paragraph></subsection><subsection id="id4784937C2EA94BFCACAC4DB54C3AB327"><enum>(b)</enum><header>Identification
				of procedures</header><text>For purposes of subsection (a), the Secretary shall
				identify—</text>
						<paragraph id="ID3ec1d9e8dd814272b10026db400f8345"><enum>(1)</enum><text>all hospital
				inpatient procedures for which payment is provided under section 1886(d) that
				involve the implantation of a medical device; and</text>
						</paragraph><paragraph id="IDfbecf69de74b46c79179ce4f9b19b067"><enum>(2)</enum><text>all hospital
				outpatient procedures for which payment is provided under section 1833(t) that
				involve the implantation of a medical device.</text>
						</paragraph></subsection><subsection id="idEE9B353318EE4E6AACB20027F1E1441D"><enum>(c)</enum><header>Public
				availability</header><text>Not later than April 30, 2009, the Secretary shall
				establish procedures to ensure that the information reported under subsection
				(a) is readily accessible to the public through the Internet website of the
				Centers for Medicare &amp; Medicaid Services in a manner that is easily
				searchable, downloadable, and understandable. Such procedures shall ensure that
				the website is updated each quarter as new information is reported under such
				subsection.</text>
					</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body>
</bill>
